SAN FRANCISCO, Feb. 28, 2019 /PRNewswire/ — Trianni, Inc. (“TRIANNI”) announced today that the Japan Patent Office granted the patent for TRIANNI’s leading technology, The […]
INC: Cashews May Have Fewer Calories Than Previously Thought – New Scientific Findings
REUS, Spain, Feb. 27, 2019/PRNewswire/ — In a human-intervention trial published recently in the journal Nutrients, researchers at the USDA, ARS, Beltsville Human Nutrition Research Center, […]
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards
HONG KONG, Feb. 27, 2019 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), today announced that it received the International Finance Review (IFR) Asia-Pacific IPO […]
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today
HONG KONG, Feb. 27, 2019 /PRNewswire/ — CStone Pharmaceuticals (Stock code: 2616) today announced the listing of 186,396,000 shares on the Main Board of the […]
Blackford Analysis Commended by Frost & Sullivan for its Visionary Implementation of Platform-based Approaches in the Medical Imaging Space
Its platform streamlines the implementation of multiple solutions, accelerating their deployment from years to weeks SANTA CLARA, California, Feb. 26, 2019 /PRNewswire/ — Based on its […]
Focusing on Advanced Laboratory Instruments and Equipment, Building an All-around Live-action Space — 2019 InnoLAB Salon Formally Kicked Off
SHANGHAI, Feb. 26, 2019 /PRNewswire/ — The InnoLAB Salon this session will be divided into four themes: Intelligent Lab, Chromatography, Particle Sizer Analytical Technology, and […]
Top 3 Growth Opportunities for Digital Pathology-enabling Technology Companies
Establishment of parallel workflows vital to gain regulatory approvals for the use of artificial intelligence capabilities in digital pathology, finds Frost & Sullivan SANTA CLARA, […]
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer
TAIPEI, Taiwan, February 21, 2019 /PRNewswire/ — Foresee Pharmaceuticals Co., Ltd. (6576.TWO) (“Foresee”), announced today the topline results of FP-001 LMIS (Leuprolide Mesylate Injectable Suspension) […]
Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease
— Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol — STAINES-UPON-THAMES, United Kingdom, Feb. […]
Shanghai Concord Medical Cancer Center’s Basic Medical Services have been Fully Covered by Medical Insurance
BEIJING, Feb. 20, 2019 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solution provider […]
